ADCYAP1 and melanoma: In our previous experiments, PACAP reduced the motility of melanoma cells in vitro, and on the basis of the currently presented data we propose that one of the factors behind this phenomenon can be the balancing effect of PACAP on melanoma HA homeostasis.